TrialCPT: pharmacometrics & systems pharmacology2016

Weight-HbA1c-insulin-glucose model for describing disease progression of type 2 diabetes.

S Choy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.